Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
暂无分享,去创建一个
C. Swanton | D. Moore | A. Akarca | T. Marafioti | S. Janes | Roel P. H. De Maeyer | A. Akbar | R. Hynds | T. Karasaki | V. Reddy | A. Huebner | K. Shah | N. Mcgranahan | E. Kostina | D. Pearce | Monica Sivakumar | Emily Kostina | R. D. De Maeyer
[1] A. Rowan,et al. Genomic evolution of non-small cell lung cancer patient-derived xenograft models , 2023, bioRxiv.
[2] C. Swanton,et al. Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories , 2020, Open Biology.
[3] Sanghyuk Lee,et al. PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications , 2020, Journal of Translational Medicine.
[4] J. Rehg,et al. Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors , 2020, Veterinary pathology.
[5] J. Roth,et al. Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice , 2019, Cancer.
[6] C. Watson,et al. Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire , 2018, Front. Immunol..
[7] Jae Woo Choi,et al. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation. , 2018, Lung cancer.
[8] A. Rickinson,et al. Epstein–Barr virus-associated lymphomas , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.
[9] D. Visscher,et al. Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts12 , 2017, Neoplasia.
[10] Nicolai J. Birkbak,et al. Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[11] C. von Kalle,et al. Patient‐derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B‐lymphoproliferation , 2017, International journal of cancer.
[12] H. Veelken,et al. Germline mutations predisposing to diffuse large B-cell lymphoma , 2017, Blood Cancer Journal.
[13] J. McPherson,et al. Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors , 2017, International journal of cancer.
[14] Yoon Young Choi,et al. Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer , 2016, Scientific Reports.
[15] Chi-Ping Day,et al. Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges , 2015, Cell.
[16] T. O’Halloran,et al. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors1 , 2015, Neoplasia.
[17] A. Cope,et al. Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus , 2015, European journal of immunology.
[18] D. Scott. Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic? , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[19] A. Rickinson,et al. The immunology of Epstein-Barr virus-induced disease. , 2015, Annual review of immunology.
[20] J. Ji,et al. The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice , 2015, Scientific Reports.
[21] L. Bubendorf,et al. Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out Immunocompromised mice , 2015, The Prostate.
[22] P. Vrignaud,et al. Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps , 2014, Cancer medicine.
[23] Y. Ohnishi,et al. Characterization of EBV-related Lymphoproliferative Lesions Arising in Donor Lymphocytes of Transplanted Human Tumor Tissues in the NOG Mouse , 2014, Experimental animals.
[24] Mark Cobbold,et al. Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study , 2014, PLoS biology.
[25] Mahadev Satyanarayanan,et al. OpenSlide: A vendor-neutral software foundation for digital pathology , 2013, Journal of pathology informatics.
[26] M. Tsao,et al. Characterization of Lymphomas Developing in Immunodeficient Mice Implanted With Primary Human Non–Small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] J. Dick,et al. Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus , 2012, PloS one.
[28] Michael Becker,et al. Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers , 2008, Clinical Cancer Research.
[29] T. Molina,et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2007, Leukemia.
[30] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[31] S. Pileri,et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. , 2003, Blood.
[32] F. Berger,et al. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma , 2003, The Lancet.
[33] A. Lanzavecchia,et al. kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire , 1995, The Journal of experimental medicine.
[34] J. Steitz,et al. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.